Assenagon Asset Management S.A.

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1546007 SENNINGERBERG, N4

Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$860,749

-$1,036,978 QoQ

Shares Held

59,403

-56.6% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 58 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. RDY ranks #17 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	3,056,017	$103,537,855
2	LNTH	Lantheus Holdings, Inc.	714,980	$79,319,881
3	VTRS	Viatris Inc	4,989,006	$79,225,415
4	INDV	Indivior Pharmaceuticals, Inc.	1,540,928	$63,224,275
5	UTHR	UNITED THERAPEUTICS Corp	84,538	$45,805,224
6	AMRX	Amneal Pharmaceuticals, Inc.	2,445,549	$42,332,453
7	NBIX	Neurocrine Biosciences Inc	222,606	$37,518,015
8	ZTS	Zoetis Inc.	389,335	$27,977,613

All Filings in RDY

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$860,749	59,403	-56.6%	Shares	Sole	2026-07-08
2026-03-31	$1,897,727	137,020	+128.2%	Shares	Sole	2026-04-20
2024-06-30	$4,575,057	60,048	-62.5%	Shares	Sole	2024-07-18
2024-03-31	$11,754,484	160,252	-18.3%	Shares	Sole	2024-04-24
2023-12-31	$13,647,838	196,146	+416.1%	Shares	Sole	2024-01-17
2023-09-30	$2,541,394	38,005	-77.2%	Shares	Sole	2023-11-06
2023-06-30	$10,518,354	166,667	-33.0%	Shares	Sole	2023-07-25
2023-03-31	$14,153,708	248,616	+26.8%	Shares	Sole	2023-04-18
2022-12-31	$10,144,966	196,038	+210.6%	Shares	Sole	2023-01-12
2022-09-30	$3,303,753	63,121	—	Shares	Sole	2022-10-27
No filing history on record for this holder in this stock.